
TRIANA Biomedicines
Unlocking the full potential of molecular glues to develop precision medicines and transform patient lives
TRIANA Biomedicines was founded in 2022, is headquartered in Lexington, United States, lists 11–50 employees, and has $230.0M in recorded funding across 2 rounds.
- Headquarters
- Lexington, Massachusetts
- Employees
- 11–50
- Founded
- 2022
- Business Model
- B2B
- Website
- trianabio.com
- Total Funding
- $230.0M
- Last Round
- $120.0M Series BDec 2025
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 11 investors for this company. The full record is or through the API.
About
TRIANA Biomedicines is a venture-backed biopharmaceutical company pioneering the discovery and development of molecular glue therapeutics to treat cancers and other diseases with historically undruggable targets. Founded in 2022 and headquartered in Lexington, Massachusetts, TRIANA uses a proprietary protein:protein pairing engine and target-first methodology to identify small molecules that promote interactions between two proteins, enabling the ubiquitin-proteasome system to degrade disease-causing proteins. The company's initial focus is targeted protein degradation in oncology, including ALK-positive non-small cell lung cancer (NSCLC), with a pipeline designed to address targets inadequately served by existing therapies. TRIANA raised a $120M Series B in December 2025, bringing total funding to $230M, to advance its molecular glue degrader pipeline toward clinical development.
Summary
TRIANA Biomedicines is a Biotech company based in Lexington, United States, founded in 2022. It lists 11–50 employees. It has raised $230.0M in total across 2 rounds, most recently a $120.0M Series B round in Dec 2025. Investors include Ascenta Capital, Lightspeed Venture Partners and Pfizer Ventures.
Tech & App Stack
1 technology or app tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Dec 2025
Sign up to see all 2 events
Funding: Series A through Series B. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...

Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/triana-biomedicines"><img src="https://indexed.vc/api/badge/company/triana-biomedicines" alt="TRIANA Biomedicines on Indexed.vc" width="260" height="76" /></a>


